Pharmaceutical Investing AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec
Pharmaceutical Investing Arvinas Announces Data Presentations from the Vepdegestrant Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium
Pharmaceutical Investing Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Pharmaceutical Investing U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
Pharmaceutical Investing Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company's Board of Directors
Pharmaceutical Investing AbbVie Announces U.S. FDA Approval of EPKINLY® in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma
Pharmaceutical Investing InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901
Stardust Metal Uncovers Large, Never-Drilled Ultramafic Target Adjacent to High-Grade Kerr Addison in Kirkland Lake
E-Power Resources Appoints New CEO and Expands Advisory Teams; Focus on Agressive Strategy for Tetepisca Graphite Project
Standard Uranium Receives Drill Permits and Initiates Ground Gravity Survey on the Corvo Uranium Project
